NEW YORK, Feb. 27, 2017 /PRNewswire/ --
y
This report provides all the information you require to better
understand The Medicines Company and its partnering interests and
activities since 2010.
Read the full report:
http://www.reportlinker.com/p03605637-summary/view-report.html
Description
The Partnering Deals and Alliance since
2010 report provides an in-depth insight into the partnering
activity of one of the world's leading life sciences companies.
On demand company reports are prepared upon purchase to ensure
inclusion of the most up to date deal and company data.
The report will be delivered in PDF format within 1 working day
of receipt of order. If the CD-Rom version purchased, the report
will be sent by courier using express service.
One of the key aspects of partnering is finding those companies
that are potential candidates for the development and
commercialization of the next generation of therapies. A lot of
resources are spent on finding partners, identifying their
interests and making contact to initiate discussions.
Using this report, dealmakers will effectively and efficiently
target their partnering activities to deliver the company's
business development objectives.
The initial chapters of this report provide an orientation of
deal making and business activities. Chapter 1 provides an
introduction to the report, whilst chapter 2 lists the top
companies partnering with the company since 2010. Chapter 3
provides an overview of the leading partnering and M&A deals
since 2010 to present date based on headline value.
Chapter 4 provides details on how to approach biopharma
companies with partnering opportunities whilst chapter 5 lists
forthcoming partnering events and conferences where biopharma
companies will be present to discuss opportunities face to
face.
The main body of the report is provided in chapter 6 providing a
infographic visual summary of the company's partnering activity
since 2010 according to deal type, industry sector, phase of
development, and therapy area.
The deals are listed by deal type, stage of development and
therapy focus, allowing easy access to deals and alliances of
interest. Every deal record links to an online, live version of the
deal record at the Current Agreements deals and alliances database.
Where available, deal records also include the contract document as
disclosed at the SEC.
One of the key aspects of partnering is conducting due diligence
on a partner to determine under what terms a prospective partner
agrees to a partnering relationship.
Understanding the flexibility of prospective partners'
negotiated deals terms provides critical insight into the
negotiation process in terms of what you can expect to achieve
during the negotiation of terms. Whilst many smaller companies will
be seeking details of the payments clauses, the devil is in the
detail in terms of how payments are triggered – contract documents
provide this insight where press releases and databases do not.
In addition, contract documents provide the answers to numerous
questions about a prospective partner's flexibility on a wide range
of important issues, many of which will have a significant impact
on each party's ability to derive value from the deal.
Each contract document is accessible through a link to an online
version of the actual contract document as filed with the
Securities Exchange Commission.
Analyzing actual company agreements allows assessment of the
following:
- What is actually granted by the agreement to the partner
company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and sub-contracting provisions have been
agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to
partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement
law?
Read the full report:
http://www.reportlinker.com/p03605637-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/the-medicines-company-partnering-deals-and-alliances-2010-to-2017-300414515.html
SOURCE Reportlinker